Diarrhea-Predominant Irritable Bowel Syndrome
Conditions
Interventions
Control group:Conventional drug therapy
Sponsors
Changchun University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Meets the diagnostic criteria for Rome IV criteria for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D). 2.Age =18 years old, regardless of gender 3.Duration of disease =6 months 4.Voluntarily participating in this clinical study, agreeing to undergo relevant treatments and examinations, being able to adhere to follow-up visits and signing the informed consent form
Exclusion criteria
Exclusion criteria: 1.Participants currently diagnosed with coagulation disorders hepatitis HIV or cancer 2.Participants who have undergone major gastrointestinal surgery in the past 3 months 3.Participants who are pregnant or have a fear of needles 4.Participants currently undergoing acupuncture treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effective response rate at week 4; | — |
Secondary
| Measure | Time frame |
|---|---|
| Effective response rate at other time points;Bristol Stool Form Scale;Numerical rating scale;IBS symptom severity scale(IBS-SSS);IBS quality of life scale(IBS-QOL);Hospital Anxiety and Depression Scale (HADS);Adverse events;Expectancy Questionnaire; | — |
Countries
China
Contacts
Public ContactLi Tie
Changchun University of Chinese Medicine
Outcome results
None listed